EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel loss-of-function variants expand ABCC9 -related intellectual disability and myopathy syndrome

Stephanie Efthymiou iD, Marcello Scala iD, Vini Nagaraj, Katarzyna Ochenkowska, Fenne L Komdeur, Robin A Liang, Mohamed S Abdel-Hamid, Tipu Sultan, Tuva Barøy, Marijke Van Ghelue, Barbara Vona iD, Reza Maroofian iD und 17 weitere

Brain · 2024

DOI: 10.1093/brain/awae010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2024. Verfasst von Stephanie Efthymiou und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK. Hauptthemen laut MEDLINE: Intellectual Disability, Sulfonylurea Receptors, Muscular Diseases. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NHLBI NIH HHS, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Loss-of-function mutation of ABCC9, the gene encoding the SUR2 subunit of ATP sensitive-potassium (KATP) channels, was recently associated with autosomal recessive ABCC9-related intellectual disability and myopathy syndrome (AIMS). Here we identify nine additional subjects, from seven unrelated families, harbouring different homozygous loss-of-function variants in ABCC9 and presenting with a conserved range of clinical features. All variants are predicted to result in severe truncations or in-frame deletions within SUR2, leading to the generation of non-functional SUR2-dependent KATP channels. Affected individuals show psychomotor delay and intellectual disability of variable severity, microcephaly, corpus callosum and white matter abnormalities, seizures, spasticity, short stature, muscle fatigability and weakness. Heterozygous parents do not show any conserved clinical pathology but report multiple incidences of intra-uterine fetal death, which were also observed in an eighth family included in this study. In vivo studies of abcc9 loss-of-function in zebrafish revealed an exacerbated motor response to pentylenetetrazole, a pro-convulsive drug, consistent with impaired neurodevelopment associated with an increased seizure susceptibility. Our findings define an ABCC9 loss-of-function-related phenotype, expanding the genotypic and phenotypic spectrum of AIMS and reveal novel human pathologies arising from KATP channel dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intellectual DisabilitySulfonylurea ReceptorsMuscular DiseasesHumansFemaleMaleAnimalsChildChild, PreschoolAdolescentZebrafishLoss of Function MutationAdultPedigreeYoung Adult

Stichwörter der Autor:innen

ABCC9KATP channelsSUR2neurodevelopmental disorder

Substanzen

Sulfonylurea ReceptorsABCC9 protein, human

Autor:innen und Institutionen

  • Department of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.
  • Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, 16147 Genoa, Italy.
  • U.O.C. Genetica Medica, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.
  • Center for Advanced Biotechnology and Medicine, and Departments of Pharmacology and Medicine, Robert Wood Johnson Medical School, Rutgers the State University of New Jersey, Piscatway, NJ 08854, USA.
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), and Department of Neuroscience, Université de Montréal, Montreal H2X 0A9, Quebec, Canada.
  • Section Clinical Genetics, Department of Human Genetics and Amsterdam Reproduction and Development, Amsterdam University Medical Centers, 1105 AZ, Amsterdam, The Netherlands.

ORCID-Profile: Stephanie Efthymiou, Marcello Scala, Barbara Vona, Reza Maroofian, Fowzan S Alkuraya, Mariasavina Severino, Henry Houlden, Éric Samarut

Förderung

  • NIH HHS
  • NHLBI NIH HHS
  • Wellcome Trust
  • Medical Research Council
  • International Centre for Genomic Medicine in Neuromuscular Diseases
  • The MRC
  • The MSA Trust
  • The National Institute for Health Research University College London Hospitals Biomedical Research Centre

Zitieren

APA

Efthymiou, S., Scala, M., Nagaraj, V., Ochenkowska, K., Komdeur, F. L., Liang, R. A., Abdel-Hamid, M. S., Sultan, T., Barøy, T., Van Ghelue, M., Vona, B., Maroofian, R., Zafar, F., Alkuraya, F. S., Zaki, M. S., Severino, M., Duru, K. C., Tryon, R. C., Brauteset, L. V., …, & McClenaghan, C. (2024). Novel loss-of-function variants expand ABCC9 -related intellectual disability and myopathy syndrome. Brain. https://doi.org/10.1093/brain/awae010

Vancouver

Efthymiou S, Scala M, Nagaraj V, Ochenkowska K, Komdeur FL, Liang RA, et al. Novel loss-of-function variants expand ABCC9 -related intellectual disability and myopathy syndrome. Brain. 2024. doi:10.1093/brain/awae010

BibTeX
@article{Efthymiou2024,
  author = {Efthymiou, Stephanie and Scala, Marcello and Nagaraj, Vini and Ochenkowska, Katarzyna and Komdeur, Fenne L and Liang, Robin A and Abdel-Hamid, Mohamed S and Sultan, Tipu and Barøy, Tuva and Van Ghelue, Marijke and Vona, Barbara and Maroofian, Reza and Zafar, Faisal and Alkuraya, Fowzan S and Zaki, Maha S and Severino, Mariasavina and Duru, Kingsley C and Tryon, Robert C and Brauteset, Lin Vigdis and Ansari, Morad and Hamilton, Mark and van Haelst, Mieke M and van Haaften, Gijs and Zara, Federico and Houlden, Henry and Samarut, Éric and Nichols, Colin G and Smeland, Marie F and McClenaghan, Conor},
  title = {Novel loss-of-function variants expand ABCC9 -related intellectual disability and myopathy syndrome},
  journal = {Brain},
  year = {2024},
  doi = {10.1093/brain/awae010}
}
Kostenlos starten →